Citius Pharmaceuticals, INC DEF 14A proxy statements

Citius Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors and ratify its independent auditor.

Citius Pharmaceuticals, Inc. announces its 2026 Annual Meeting of Stockholders to elect directors and ratify its independent auditor, alongside detailed corporate governance and executive compensation disclosures.

Citius Pharmaceuticals is holding a special meeting on June 9, 2025, to vote on increasing the authorized number of shares and potentially adjourning the meeting for further proxy solicitation.

Citius Pharmaceuticals is holding a special meeting to request stockholder approval for an amendment to their Articles of Incorporation to increase the authorized number of shares, aiming to secure future funding and strategic flexibility.

Citius Pharmaceuticals has filed definitive additional materials related to its proxy statement with the Securities and Exchange Commission.

Citius Pharmaceuticals is holding its annual meeting on March 10, 2025, to vote on key proposals including director elections, executive compensation, and increasing authorized shares.